Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | NR1I3 | Q14994 | 2/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14453519 | 0.93 | PPARG (0.37) | PPARGPPARACYP17A1ATMMAPT | |
| SCHEMBL8017774 | 0.77 | ATM (0.46) | ATMMAPTTDP1 | |
| SCHEMBL23197893 | 0.73 | ACACB (0.31) | — | |
| SCHEMBL5032659 | 0.72 | PPARG (0.40) | PPARGPPARACYP17A1MAPTTDP1 | |
| SCHEMBL6536011 | 0.71 | MAOA (0.36) | TDP1KDM4E | |
| SCHEMBL13427909 | 0.71 | MAOA (0.36) | TDP1KDM4E | |
| SCHEMBL10054669 | 0.71 | PPIB (0.32) | — | |
| SCHEMBL5032656 | 0.70 | PPARG (0.41) | PPARGPPARACYP17A1ATMMMP1 | |
| SCHEMBL22234380 | 0.69 | MAOA (0.33) | KDM4E | |
| SCHEMBL8019850 | 0.69 | MAOA (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080176339-A1 | NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2008-07-24 | — | — | US | disclosed |
| US-20080176339-A1 | NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2008-07-24 | — | — | US | disclosed |
| US-20080176339-A1 | NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2008-07-24 | — | — | US | disclosed |
| US-20070166228-A1 | Neutral labeling reactants and conjugates derived thereof | WALLAC OY (FI) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166228-A1 | Neutral labeling reactants and conjugates derived thereof | NAAA, DNPEP, PAM | PPARG 1303/4885PPARA 1351/4885CYP17A1 4192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.